Increased eosinophil levels in COPD were associated with impaired abdominal aortic dynamics, highlighting a mechanistic link ...

Dividing the cohort based on blood eosinophil count revealed a larger drop in exacerbation rate with tezepelumab, with decreases of 37% (rate ratio = 0.63; 95% CI, 0.43-0.93) in the 150 cells/ μ ...

Drilling down into the data, however, there was a 37% reduction in exacerbations in a subgroup of patients with a baseline eosinophil count (BEC) 150 cells/μL or more, a population that Amgen and ...

GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD).

Corticosteroids cause profound eosinophilia, manifested by a decrease in the eosinophil count to < 25 cells/mm 3. Corticosteroid-induced eosinophilia is also caused by the redistribution phenomenon.

Find the latest CI Marret Alternative Absolute Return Bond ETF Common Units (CMAR.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.